miRagen Promotes Diana Escolar to Chief Medical Officer

Diana Escolar has been appointed chief medical officer of miRagen Therapeutics (NASDAQ: [[ticker:MGEN]]). Escolar joined the Boulder, CO, biotech in 2018 as senior vice president of clinical sciences. She will be taking on the duties of Paul Rubin, miRagen’s executive vice president of R&D. The company says Rubin will leave at the end of this year to spend more time with his family. This week, miRagen announced a restructuring and strategy shift to focus its resources on its preclinical compound for idiopathic pulmonary fibrosis.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.